Clinical Trial Update: Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update describing safety and pharmacokinetics evaluation of LPX-TI641 in adults with atopic dermatitis and psoriasis. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Psoriasis

Drugs mentioned

• LPX-TI641

Snippet

Sponsor: LAPIX Therapeutics Inc. | Conditions: Atopic Dermatitis (AD), Psoriasis (PsO) | Phase 1 | Status: RECRUITING